Yarrow Bioscience
YARW37.95512.99% ( +4.365 )
Yarrow Bioscience (YARW)
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases....
- Open
- 34.440
- High
- 39.990
- Low
- 34.440
- Prev. Close
- 33.590
- Volume
- 39.74K
- Turnover
- 1.50M
- Avg Price
- 37.717
- Bid/Ask Ratio
- --
- Amplitude
- 16.52%
- 52wk High
- 39.990
- Volume Ratio
- 0.00
- Turnover Ratio
- 6.50%
Yarrow Bioscience Analyst Rating
View MoreForecast & Rating
Aug 3, 2026Price forecast
$58.0052.81%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 15 hours ago
Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE
- benzinga_article · 1 day ago, 09:24 AM
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
- businessinsider · Jul 25 at 12:59 AM
VYNE Therapeutics trading halted, news pending
- benzinga_article · Jul 24 at 03:35 AM
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- PUBT · Jul 23 at 03:50 PM
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24
- StockTitan · Jul 23 at 07:26 AM
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience | VYNE Stock News
